Biliary Atresia Study in Infants and Children
ConditionBiliary Atresia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6-20
SponsorArbor Research Collaborative for Health
About this trial
Little is known about the factors that cause biliary atresia nor the factors that influence disease progression. The purpose of this study is to collect the pertinent clinical information, genetic material and body fluid samples to enable investigators to address the following aims: To identify the gene or genes implicated in the etiology of BA; To characterize the natural history of the older, non-transplanted child with BA.
Eligibility criteria
Qualifiers
Participants need to have a confirmed diagnosis of BA determined by chart review including review of pertinent diagnostic biopsy reports, radiologic reports and surgical reports (if surgery was performed).
Participants need to be >6 months of age up to and equal to the age of 20 (participants enrolled at 20 years of age will have one visit).
Participants with their native liver.
Parent, guardian or participant (if 18 years of age or older) is willing to provide informed consent and, when appropriate, the participant is willing to assent.
Disqualifiers
Currently participating in the ChiLDReN study PROBE.
Inability to confirm original diagnostic evaluation of biliary atresia.
Inability or unwillingness of family or participant to participate in all scheduled visits.
History of liver transplantation.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
1,265 Participants
are grouped into 1 trial groupSponsors and collaborators
Arbor Research Collaborative for Health
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Source ClinicalTrials.gov